These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 24229326)

  • 1. Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.
    Morris G; Maes M
    BMC Med; 2013 Sep; 11():205. PubMed ID: 24229326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.
    Morris G; Maes M
    Metab Brain Dis; 2014 Mar; 29(1):19-36. PubMed ID: 24557875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).
    Morris G; Berk M; Galecki P; Maes M
    Mol Neurobiol; 2014 Apr; 49(2):741-56. PubMed ID: 24068616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways.
    Morris G; Anderson G; Maes M
    Mol Neurobiol; 2017 Nov; 54(9):6806-6819. PubMed ID: 27766535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Campen CLMCV; Rowe PC; Visser FC
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056336
    [No Abstract]   [Full Text] [Related]  

  • 6. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.
    Maes M
    Mod Trends Pharmacopsychiatry; 2013; 28():162-74. PubMed ID: 25224898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors.
    Wirth K; Scheibenbogen C
    Autoimmun Rev; 2020 Jun; 19(6):102527. PubMed ID: 32247028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression.
    Maes M; Mihaylova I; Kubera M; Leunis JC; Twisk FN; Geffard M
    Metab Brain Dis; 2012 Dec; 27(4):415-23. PubMed ID: 22614823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.
    Morris G; Maes M
    Metab Brain Dis; 2013 Dec; 28(4):523-40. PubMed ID: 22718491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deconditioning does not explain orthostatic intolerance in ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome).
    van Campen CLMC; Rowe PC; Visser FC
    J Transl Med; 2021 May; 19(1):193. PubMed ID: 33947430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS.
    Maes M; Twisk FN
    Neuro Endocrinol Lett; 2009; 30(6):677-93. PubMed ID: 20038921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative and Nitrosative Stress and Immune-Inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).
    Morris G; Maes M
    Curr Neuropharmacol; 2014 Mar; 12(2):168-85. PubMed ID: 24669210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of autoimmune responses to oxidative specific epitopes, but not nitroso-adducts, is associated with a better clinical outcome in Myalgic Encephalomyelitis/chronic fatigue syndrome.
    Maes M; Leunis JC
    Neuro Endocrinol Lett; 2014; 35(7):577-85. PubMed ID: 25617880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
    Maes M; Bosmans E; Kubera M
    Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder.
    Maes M; Mihaylova I; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
    Neuro Endocrinol Lett; 2009; 30(4):470-6. PubMed ID: 20010505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
    Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
    J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    van Campen CLMC; Rowe PC; Visser FC
    Clin Neurophysiol Pract; 2021; 6():245-255. PubMed ID: 34667909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
    Front Immunol; 2019; 10():796. PubMed ID: 31057538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
    Huth TK; Brenu EW; Ramos S; Nguyen T; Broadley S; Staines D; Marshall-Gradisnik S
    Scand J Immunol; 2016 Jan; 83(1):44-51. PubMed ID: 26381393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways.
    Maes M; Twisk FN
    BMC Med; 2010 Jun; 8():35. PubMed ID: 20550693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.